C. Lu et al., ENDOGENOUS INTERLEUKIN-6 CAN FUNCTION AS AN IN-VIVO GROWTH-STIMULATORY FACTOR FOR ADVANCED-STAGE HUMAN-MELANOMA CELLS, Clinical cancer research, 2(8), 1996, pp. 1417-1425
We have previously shown that a majority of human melanoma cell lines
derived from early-stage lesions were growth inhibited by exogenous in
terleukin 6 (IL-6) irt vitro, whereas cell lines from advanced-stage l
esions were resistant to such IL-6-induced growth inhibition, Among th
e resistant melanoma cell lines, 50-60% constitutively produced IL-6,
which appeared to function as a growth stimulator irt vitro, based on
the growth-suppressive effects of antisense oligonucleotides to the IL
-6 gene, The present study was primarily aimed at evaluating whether e
ndogenous IL-6 also functions in vivo as a growth modulator for IL-6-p
roducing and -nonproducing melanoma cells, To do so, we first introduc
ed an IL-6 expression vector into IL-6-nonproducing human melanoma cel
ls using WM35, an early-stage (radial growth phase) cell line, the gro
wth of which is normally inhibited by IL-6, and WM983A, an advanced-st
age cell line, the growth of which in vitro is not affected by exogeno
us IL-6. None of the IL-6-producing transfectants showed a significant
alteration in tumor growth in nude mice, Next, two IL-6-producing mel
anoma cell lines, both of which were derived from metastases, MeWo and
WM9, and which are growth resistant to exogenously added IL-6, were t
ransfected with an antisense IL-6 expression vector, Several transfect
ant clones manifested a constitutive decrease in IL-6 gene expression
and protein production, and they also gave rise to much smaller tumors
with slower growth rates and longer latency periods, However, these I
L-6 antisense transfectants were not growth suppressed in in vitro cel
l cultures, relative to their respective parental controls, Taken toge
ther, the results demonstrate that endogenous IL-6 can indeed function
as a growth stimulator for human cutaneous melanomas in vivo. This gr
owth-stimulatory or survival mechanism remains to be clarified but may
be paracrine rather than autocrine in nature.